8NQ-16790-77309
4 vaccinations
5 coded responses
48 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 460 / IN
- Registered
- 2021-01-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Registered in v-safe
-
2021-01-08
Dose 1 — Pfizer-BioNTech
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
-
2021-01-29
Dose 2 — Pfizer-BioNTech
- 2021-01-29
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness, NauseaAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-21
- 2021-02-28
-
2021-03-05
Survey response — day 35, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-12
- 2021-04-30
- 2021-07-30
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
-
2021-10-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Headache, DiarrheaAdult check-in
- 2021-10-02
- 2021-10-05
- 2021-10-06
- 2021-10-09
-
2021-10-14
Survey response — day 14, dose 3MedDRA: Diarrhoea — Feeling: FairFree text: DiarrheaMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Survey response — day 21, dose 3MedDRA: Nasal congestion — Feeling: FairFree text: Nasal congestionMedDRA releases: 2024-11 · check-in free text available
- 2021-11-06
- 2021-11-15
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Rhinorrhoea, Throat irritation — Feeling: GoodFree text: Scratchy throat and runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-09-16
Dose 4 — Pfizer-BioNTechCo-administered: Flu
-
2022-09-16
Health check-in — day 0, dose 4Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body achesAdult check-in
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-21
- 2022-09-23
- 2022-10-02
- 2022-10-07
- 2022-10-15
- 2022-10-23
- 2022-10-28
- 2022-12-16
-
2023-03-17
Survey response — 6 months, dose 4MedDRA: Influenza, SARS-CoV-2 test negative, Streptococcal infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-17
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-09-16 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 5 — day 35, dose 2
Symptoms: Cold symptoms
Release 10 — day 14, dose 3
Symptoms: Diarrhea
Release 10 — day 21, dose 3
Symptoms: Nasal congestion
Release 10 — 3 months, dose 3
Symptoms: Scratchy throat and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | · | · | ✓ |
| SD | Influenza | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Streptococcal infection | · | · | ✓ |
| SD | Throat irritation | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release